Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 968794, 7 pages
http://dx.doi.org/10.1155/2014/968794
Research Article

Expression of Mesothelioma-Related Markers in Meningiomas: An Immunohistochemical Study

Department of Pathology, Faculty of Medicine, University of Alexandria, Alexandria 21533, Egypt

Received 13 February 2014; Accepted 11 April 2014; Published 30 April 2014

Academic Editor: Jens Schittenhelm

Copyright © 2014 Eman Abdelzaher and Dina Mohamed Abdallah. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Iwami, A. Natsume, M. Ohno et al., “Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model,” Neuro-Oncology, vol. 15, no. 6, pp. 747–758, 2013. View at Google Scholar
  2. M. Shintaku, T. Honda, and T. Sakai, “Expression of podoplanin and calretinin in meningioma: an immunohistochemical study,” Brain Tumor Pathology, vol. 27, no. 1, pp. 23–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Perry, “Meningiomas,” in Russel & Rubinstein’s Pathology of Tumors of the Nervous System, R. E. McLendon, M. K. Rosenblum, and D. D. Bigner, Eds., pp. 427–474, Arnold, London, UK, 7th edition, 2006. View at Google Scholar
  4. A. Assi, P. Declich, M. Iacobellis, L. Cozzi, and G. Tonnarelli, “Secretory meningioma, a rare meningioma subtype with characteristic glandular differentation: an histological and immunohistochemical study of 9 cases,” Advances in Clinical Pathology, vol. 3, no. 3, pp. 47–53, 1999. View at Google Scholar · View at Scopus
  5. C. J. Pan, “The ultrastructural and immunohistochemical observations of anaplastic meningioma,” Zhonghua Bing Li Xue Za Zhi, vol. 21, no. 4, pp. 224–226, 1992. View at Google Scholar · View at Scopus
  6. N. Al-Saffar and P. S. Hasleton, “Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions,” European Respiratory Journal, vol. 3, no. 9, pp. 997–1001, 1990. View at Google Scholar · View at Scopus
  7. A. Wasilewska, J. Ryś, and A. Niezabitowski, “Ultrastructure of diffuse malignant mesothelioma of the pleura. An analysis of ten cases,” Patologia Polska, vol. 44, no. 2, pp. 95–100, 1993. View at Google Scholar · View at Scopus
  8. H. Takei, M. B. Bhattacharjee, A. Rivera, Y. Dancer, and S. Z. Powell, “New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors,” Archives of Pathology and Laboratory Medicine, vol. 131, no. 2, pp. 234–241, 2007. View at Google Scholar · View at Scopus
  9. A. Perry, D. N. Louis, B. W. Scheithauer, H. Budka, and A. von Deimling, “Meningeal tumors,” in WHO Classification of Tumors of the Central Nervous System, D. N. Louis, H. Ohgaki, O. D. Wiestler, and W. K. Cavenee, Eds., pp. 164–172, IARC Press, Lyon, France, 4th edition, 2007. View at Google Scholar
  10. Z. O. Toktas, E. Akgun, A. Ozkan et al., “Relationship of angiogenic potential with clinical features in cranial meningiomas: a corneal angiogenesis study,” Neurosurgery, vol. 67, no. 6, pp. 1724–1732, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Abdelzaher, N. M. El Deeb, A. G. Gowil, and A. Yehya, “Biological and demographic profile of meningiomas in a cohort of egyptian patients: impact on tumor recurrence,” The Scientific World Journal, vol. 2013, Article ID 375139, 8 pages, 2013. View at Publisher · View at Google Scholar
  12. J. Shibahara, T. Kashima, Y. Kikuchi, A. Kunita, and M. Fukayama, “Podoplanin is expressed in subsets of tumors of the central nervous system,” Virchows Archiv, vol. 448, no. 4, pp. 493–499, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Nakamura, Y. Kanemura, T. Yamada et al., “D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells,” Modern Pathology, vol. 19, no. 7, pp. 974–985, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. N. G. Ordóñez, “The immunohistochemical diagnosis of mesothelioma,” The American Journal of Surgical Pathology, vol. 27, pp. 1031–1051, 2003. View at Google Scholar
  15. N. G. Ordóñez, “What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update,” Human Pathology, vol. 38, no. 1, pp. 1–16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. King, N. Thatcher, C. A. C. Pickering, and P. S. Hasleton, “Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data,” Histopathology, vol. 48, no. 3, pp. 223–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. N. G. Ordóñez, “Value of podoplanin as an immunohistochemical marker in tumor diagnosis: a review and update,” Applied Immunohistochemistry & Molecular Morphology. In press.
  18. H. P. Hahn, E. A. Bundock, and J. L. Hornick, “Immunohistochemical staining for Claudin-1 can help distinguish meningiomas from histologic mimics,” The American Journal of Clinical Pathology, vol. 125, no. 2, pp. 203–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. Rivera, H. Takei, M. B. Bhattacharjee, A. Adesina, J. C. Goodman, and S. Z. Powell, “Claudin-1 versus EMA staining in low and high grade meningiomas,” The FASEB Journal, vol. 21, pp. 555–554, 2007. View at Google Scholar
  20. J. M. Theaker, K. C. Gatter, M. M. Esiri, and K. A. Fleming, “Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study,” Journal of Clinical Pathology, vol. 39, no. 4, pp. 435–439, 1986. View at Google Scholar · View at Scopus
  21. A. Artlich and D. Schmidt, “Immunohistochemical profile of meningiomas and their histological subtypes,” Human Pathology, vol. 21, no. 8, pp. 843–849, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. H. D. Mennel, J. Zinngrebe, U. Berweiler-Nippert, and H. Lorenz, “Meningiomas: histogenesis and classification. A comparative morphological study,” Zentralblatt fur Allgemeine Pathologie und Pathologische Anatomie, vol. 134, no. 1, pp. 27–40, 1988. View at Google Scholar · View at Scopus
  23. J. T. Huse, T. L. Pasha, and P. J. Zhang, “D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma,” Acta Neuropathologica, vol. 113, no. 1, pp. 87–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. N. G. Ordóñez, “D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma,” Human Pathology, vol. 36, no. 4, pp. 372–380, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. K. S. W. Bellucci, X. Xu, C. C. R. Lee et al., “D2-40 immunoreactivity in spindle cell tumors, a specific endothelial marker?” Modern Pathology, vol. 17, supplement 1, 10A (abstract # 27), 2004. View at Google Scholar
  26. K. Mishima, Y. Kato, M. K. Kaneko et al., “Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma,” Acta Neuropathologica, vol. 111, no. 6, pp. 563–568, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Hayashi, R. Haba, Y. Kushida et al., “Cytopathologic features of orbital intraosseous chordoid meningioma: report of a case and distinction from other myxoid/mucoid tumors,” Diagnostic Cytopathology, vol. 38, no. 11, pp. 818–821, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-L. Zhao, Y. Li, X.-Y. Tian, Z. Li, Q. Huang, and B. Li, “Intraparenchymal cystic chordoid meningioma: a case report and review of the literature,” Neuropathology, vol. 31, no. 6, pp. 648–653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. R. Sangoi, M. S. Dulai, A. H. Beck, D. J. Brat, and H. Vogel, “Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation,” The American Journal of Surgical Pathology, vol. 33, no. 5, pp. 669–681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Doglioni, A. P. Dei Tos, L. Laurino et al., “Calretinin: a novel immunocytochemical marker for mesothelioma,” The American Journal of Surgical Pathology, vol. 20, no. 9, pp. 1037–1046, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Regelsberger, C. Hagel, P. Emami, T. Ries, O. Heese, and M. Westphal, “Secretory meningiomas: a benign subgroup causing life-threatening complications,” Neuro-Oncology, vol. 11, no. 6, pp. 819–824, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. X.-J. Li, H.-Y. Zhang, Z.-Q. Lang, B. Wei, H.-L. Chen, and H. Bu, “Analysis of clinical and pathological features of secretory meningiomas,” Journal of Sichuan University (Medical Science Edition), vol. 37, no. 3, pp. 488–491, 2006. View at Google Scholar · View at Scopus
  33. H.-Y. Cho, M. Lee, H. Takei, J. Dancer, J. Y. Ro, and Q. J. Zhai, “Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma,” Applied Immunohistochemistry and Molecular Morphology, vol. 17, no. 2, pp. 131–138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. L. Tena-Suck, M. A. Collado-Ortìz, C. Salinas-Lara, R. García-López, N. Gelista, and D. Rembao-Bojorquez, “Chordoid meningioma: a report of ten cases,” Journal of Neuro-Oncology, vol. 99, no. 1, pp. 41–48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Budka, “Non-glial specificities of immunocytochemistry for the glial fibrillary acidic protein (GFAP). Triple expression of GFAP, vimentin and cytokeratins in papillary meningioma and metastasizing renal carcinoma,” Acta Neuropathologica, vol. 72, no. 1, pp. 43–54, 1986. View at Google Scholar · View at Scopus
  36. L. Zhi, L. Bing, L. Yang, L. Bo-ning, and H. Quan, “Cystic papillary meningioma with subarachnoid dissemination: a case report and review of the literature,” Pathology Research and Practice, vol. 205, no. 8, pp. 582–587, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. M. D. Fox, S. D. Billings, B. C. Gleason, A. B. Thomas, and T. L. Cibull, “Cutaneous meningioma: a potential diagnostic pitfall in p63 positive cutaneous neoplasms,” Journal of Cutaneous Pathology, vol. 40, no. 10, pp. 891–895, 2013. View at Google Scholar
  38. A. Singh, A. K. Mishra, K. Ylaya, S. M. Hewitt, K. C. Sharma, and S. Saxena, “Wilms tumor-1, claudin-1 and ezrin are useful immunohistochemical markers that help to distinguish schwannoma from fibroblastic meningioma,” Pathology and Oncology Research, vol. 18, no. 2, pp. 383–389, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Mokhtari, M. Sadeghi, and A. Talebi, “Monoclonal antibody HBME-1 usefulness in differentiation of benign neoplasm and differentiated thyroid carcinoma,” Acta Medica Iranica, vol. 43, no. 2, pp. 85–88, 2005. View at Google Scholar · View at Scopus
  40. H. Battifora and W. T. E. McCaughey, Tumors of the Serous Membranes, American Registry of Pathology, Washington, DC, USA, 3rd edition, 1995.
  41. M. J. Riemenschneider, A. Perry, and G. Reifenberger, “Histological classification and molecular genetics of meningiomas,” The Lancet Neurology, vol. 5, no. 12, pp. 1045–1054, 2006. View at Publisher · View at Google Scholar · View at Scopus